NSE: CIPLA: Rs.1,558.55 (+9.89%)
Cipla is engaged in the Business of Pharmaceuticals.CIPLA announced yesterday Q2 result for FY25.CIPLA Q2 Results: Revenue rose by 5.00% year-over-year (YoY) to Rs. 7051 crore, while net profit rose by 12.00% YoY to Rs. 1305 crore.
Revenue for the current quarter (Sep 2024) is Rs. 7051 crore which is Rs. 6694 crore more than the revenue in the previous quarter (Jun 2024). However, it is higher than the revenue for the same quarter last year (Sep 2023) which was Rs. 6678 crore.
Net Profit
Net Profit for the current quarter (Sep 2024) is Rs. 1305 crore, which is Rs. 1175 crore more than the net profit in the previous quarter (Jun 2024). However, compared to the same quarter last year, it is significantly higher than the net profit of Rs. 1155 crore for Sep 2023.
EPS
The EPS for the current quarter (Sep 2024) is 16, which is 14 less than the EPS for the previous quarter (Jun 2024). However, compared to the same quarter last year, it is higher than the EPS of 14 for Sep 2023.
Other Income
Other income for the current quarter (Sep 2024) is Rs. 191 crore, which is Rs. 160 crore more than the other income for the previous quarter (Jun 2024). However, compared to the same quarter last year, it is higher than the other income of Rs. 176 crore for Sep 2023.
